Researchers demonstrated AI could detect early laryngeal cancer from voice recordings, distinguishing it from benign conditions.
Key Details
- 1Laryngeal cancer affects over 1 million people worldwide, with high mortality rates.
- 2Diagnosis currently requires invasive endoscopy and biopsy; voice-based screening could simplify detection.
- 3The study analyzed 12,523 voice samples from 306 participants using the Bridge2AI-Voice dataset.
- 4Significant differences in acoustic features, especially harmonic-to-noise ratio, identified laryngeal cancer in men.
- 5Findings suggest voice could serve as a practical biomarker for cancer risk assessment, pending further validation.
Why It Matters
A non-invasive, AI-based screening tool for laryngeal cancer could enable earlier detection, reducing diagnostic delays and easing burden on specialists. This advances the potential of digital biomarkers and broadens the scope of imaging AI in oncology.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.